Menu

Revolutionize Sports Injury Recovery with Orthobiologic Treatments

Every step forward, no matter how small, is a victory worth celebrating

Ben F.: “Dr. McCormick’s meticulous approach gave me peace of mind during my treatment. His team was always available for questions, making the whole process seamless.”
20+ Years of Experience
Over 5000+ Surgeries performed
30+ Award-Winning Orthopedic Researcher
National and International Speaker
Harvard Trained and Former Harvard Faculty

Introduction

Sports medicine injuries are a common occurrence among athletes and active individuals. While surgical intervention is sometimes necessary, there has been a growing interest in non-operative orthobiologic treatment options. Orthobiologics are biological substances that are used to promote healing and regeneration of musculoskeletal tissues. This narrative review will explore the current scientific literature on non-operative orthobiologic treatment options for sports medicine injuries.

Platelet-Rich Plasma (PRP):

 – PRP is an autologous blood product that contains a high concentration of platelets and growth factors
– It is obtained by centrifuging a patient’s own blood to separate the platelet-rich fraction
– PRP has been shown to promote healing and regeneration of various musculoskeletal tissues, including tendons, ligaments, and cartilage
– Several studies have demonstrated the efficacy of PRP in treating sports medicine injuries such as lateral epicondylitis, patellar tendinopathy, and hamstring strains
– A systematic review by Fitzpatrick et al. (2017) found that PRP injections were more effective than placebo in reducing pain and improving function in patients with lateral epicondylitis
– Another systematic review by Dupley and Charalambous (2017) reported that PRP injections were superior to other non-operative treatments for patellar tendinopathy in terms of pain reduction and functional improvement
– However, the optimal preparation and administration protocols for PRP remain unclear, and further research is needed to standardize its use in clinical practice

Bone Marrow Aspirate Concentrate (BMAC):

– BMAC is a concentrate of bone marrow that contains a high concentration of mesenchymal stem cells (MSCs) and growth factors
– It is obtained by aspirating bone marrow from the iliac crest and centrifuging it to separate the cellular components
– MSCs have the ability to differentiate into various musculoskeletal tissues, including bone, cartilage, and tendon
– BMAC has been investigated as a potential treatment option for various sports medicine injuries, such as cartilage defects, meniscal tears, and rotator cuff tears
– A case series by Gobbi et al. (2017) reported that BMAC injections resulted in significant improvements in pain and function in patients with focal cartilage defects of the knee at 2-year follow-up
– Another study by Hernigou et al. (2014) found that BMAC injections were effective in promoting healing of rotator cuff tears, with a lower re-tear rate compared to conventional surgical repair
– However, the evidence for BMAC in sports medicine injuries is still limited, and more high-quality studies are needed to establish its efficacy and safety

Adipose-Derived Stem Cells (ADSCs):

– ADSCs are mesenchymal stem cells that are derived from adipose tissue
– They can be obtained through a minimally invasive liposuction procedure and have similar regenerative properties to bone marrow-derived MSCs
– ADSCs have been investigated as a potential treatment option for various sports medicine injuries, such as osteoarthritis, tendinopathy, and ligament injuries
– A randomized controlled trial by Jo et al. (2014) found that ADSCs injections were more effective than placebo in reducing pain and improving function in patients with knee osteoarthritis at 6-month follow-up
– Another study by Lee et al. (2015) reported that ADSCs injections resulted in significant improvements in pain and function in patients with lateral epicondylitis at 1-year follow-up
– However, the optimal dose and administration protocol for ADSCs in sports medicine injuries remain unclear, and further research is needed to establish their long-term efficacy and safety

Extracellular Matrix (ECM) Products:

– ECM products are derived from decellularized mammalian tissues, such as porcine small intestine submucosa or bovine pericardium
– They contain a complex mixture of structural and functional proteins, glycosaminoglycans, and growth factors that can promote tissue repair and regeneration
– ECM products have been used as scaffolds for tissue engineering and as injectable agents for treating various sports medicine injuries, such as rotator cuff tears, Achilles tendinopathy, and muscle injuries
– A case series by Rotini et al. (2011) reported that injectable porcine small intestine submucosa was effective in promoting healing of proximal hamstring tendon avulsions, with all patients returning to their pre-injury level of sports activity
– Another study by Sicari et al. (2014) found that injectable ECM derived from porcine urinary bladder matrix was safe and effective in treating volumetric muscle loss injuries, with significant improvements in muscle strength and function
– However, the evidence for ECM products in sports medicine injuries is still limited, and more high-quality studies are needed to establish their efficacy and safety

Conclusion

Non-operative orthobiologic treatment options have shown promising results in treating various sports medicine injuries. PRP, BMAC, ADSCs, and ECM products have all demonstrated the ability to promote healing and regeneration of musculoskeletal tissues in preclinical and clinical studies. However, the evidence for their efficacy and safety in sports medicine injuries is still limited, and more high-quality, randomized controlled trials are needed to establish their long-term outcomes. Additionally, the optimal preparation and administration protocols for these orthobiologic agents remain unclear, and further research is needed to standardize their use in clinical practice. Despite these limitations, orthobiologics represent a promising frontier in sports medicine, and their continued investigation may lead to the development of novel, minimally invasive treatment options for athletes and active individuals with musculoskeletal injuries.

Book An Appointment

Direct Booking Link for Consumers

Dr. McCormick schedules all virtual consultations through Best In Class MD. This is a separate service from Dr. McCormick’s in-office clinic. BICMD is a virtual platform that facilitates educational and informational sessions and can therefore be conducted for clients anywhere in the world. This comprehensive service includes a thorough review of your medical records and imaging, a 30 minute telehealth visit, as well as written recommendations provided in the form of an Expert Report. Due to the educational and informational nature of the visit, as well as the concierge nature of the booking process, insurance is not accepted for these consultations.
The BICMD care team is available to answer any questions about booking at CareTeam@bicmd.com or by calling
800-650-5907
(phone lines are open M-F 9am-5pm EST).

Orthobiologics